ICAM1 and colorectal cancer: In breast, gastric, and colorectal cancers, increased CD54 expression in the cancer cells has been correlated with more favorable prognosis, suggesting a role of CD54 in enhancement of immune surveillance (Ogawa et al., 1998; Fujihara et al., 1999; Tachimori et al., 2005).